1592: protests on small access program. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

1592: protests on small access program. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Treat News. 1997 Jun 20;(No 273):6-8. Unique Identifier : AIDSLINE MED/97702690

Abstract: Glaxo Wellcome has announced a small compassionate use program for its experimental drug, 1592 (abacavir). The program will make 1592 available to 2,500 adults and children in countries where the drug is already in clinical trials. AIDS advocates are concerned that the small size of the program will make 1592 unavailable to many people who have no other treatment options. Glaxo is having difficulties in scaling up the production process, but plans to expand the program soon. Several groups are planning protests, and the text of a 1592 Access Coalition Consensus Letter is included.

Keywords: *Anti-HIV Agents/SUPPLY & DISTRIBUTION *HIV Infections/DRUG THERAPY
971030
M97A1293

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .